IPRC (International Pharmaceutical Research Center) IPRC is a CRO established in Jordan 20 years ago and has passed successfully several EMA and five USFDA inspections (the last in Nov 2016); as well, IPRC has passed WHO inspection in 2015. Our CRO is also accredited by the Turkish MOH and successfully met the inspections conducted by South African MCC and by the Regulatory bodies in MENA and GCC. Moreover,  IPRC is approved vendor for clinical trials by Novartis, Sanofi, Pfizer and Quintiles, therefore IPRC has participated in various phases of Clinical Trials (II-IV) and is currently expanding that area. IPRC, with 100 professionals offers a broad range of services, including clinical (60 beds), bioanalytical (more than 300 analytical methods by LC-MS/MS, LC-MS or/and HPLC), Project/ trial management, Site management, Regulatory submission and support, Clinical trials conduction, Study coordination, Study monitoring. IPRC has conducted more than 1,600 bioequivalence/ bioavailability and pharmacokinetics studies submitted in EU, USA, AU, NZ, India and MENA region. IPRC has experienced Clinical Project Managers dedicated to clinical trials management, supported by experienced team of clinical research professionals (Certified Clinical Research Coordinators (cCRC), Certified Clinical Research Associates (cCRA) with continuous GCP training.